Pharma Journalist 8962 posts 0 comments

Trovagene, Inc., a clinical-stage oncology therapeutics company, taking a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of…
Read More...

CALECIM Cosmeceuticals (CALECIM), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific…
Read More...

Aequus Pharmaceuticals Inc. is pleased to announce an agreement for the Zepto Precision Pulse Capsulotomy device with The Kensington Eye Institute, a world renowned clinic and leader in…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for the supplemental New Drug…
Read More...

SMi reports: With only two weeks until SMi’s 3rd Annual Pharmaceutical Microbiology West Coast taking place in San Diego on June 5th & 6th 2019, the event has sold out! Rapid…
Read More...

Halozyme Therapeutics announced that argenx has selected a second target under the collaboration and license agreement the companies announced in February 2019. The second target…
Read More...

Gotham Therapeutics, a biotechnology company developing a novel drug class targeting RNA-modifying proteins, and ZoBio, the leading contract research organization in integrated…
Read More...

Merck, known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. announced that the companies have entered into a definitive agreement under which Merck, through…
Read More...

SMi Reports: Registration is open for SMi Group’s inaugural Wearable Injectors and Connected Devices Conference taking place in October. SMi are proud to present the inaugural…
Read More...

SGS celebrated the official opening of the Biologics, Viral Vaccine, Gene and Cell Therapy Testing facility expansion in Glasgow, UK earlier this month (Thursday May 9, 2019). The…
Read More...